Genomma Lab Internacional, S.A.B. de C.V., alongside its various operating units, specializes in the creation, promotion, and distribution of a wide array of over-the-counter (OTC) pharmaceutical goods and personal care items. Its operations span across Mexico and numerous international markets. The company's extensive product portfolio addresses diverse consumer needs, encompassing categories such as skincare, hair care, general health and wellness solutions, and pain management. Specific offerings include remedies for coughs and colds, digestive health aids, sexual well-being products, antiperspirants and deodorants, hand sanitizers, isotonic beverages, and shaving essentials. Beyond these, it also markets specialized pharmaceuticals such as analgesics, antifungals, and treatments for hemorrhoids. These products are brought to market under a multitude of well-known brands, including Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, among others. Established in 1996, Genomma Lab Internacional, S.A.B. de C.V. maintains its corporate headquarters in Mexico City, Mexico.
What is Genomma Lab Internacional SAB stock price today?▼
The current price of GNMLF is $0.84 USD — it has decreased by -0% in the past 24 hours. Watch Genomma Lab Internacional SAB stock price performance more closely on the chart.
What is Genomma Lab Internacional SAB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Genomma Lab Internacional SAB stocks are traded under the ticker GNMLF.
Is Genomma Lab Internacional SAB stock price growing?▼
GNMLF stock has fallen by -22.22% compared to the previous week, the month change is a -22.22% fall, over the last year Genomma Lab Internacional SAB has showed a -26.32% decrease.
What is Genomma Lab Internacional SAB market cap?▼
Today Genomma Lab Internacional SAB has the market capitalization of 840M
When is the next Genomma Lab Internacional SAB earnings date?▼
Genomma Lab Internacional SAB is going to release the next earnings report on July 29, 2026.
What were Genomma Lab Internacional SAB earnings last quarter?▼
GNMLF earnings for the last quarter are 0.03 USD per share, whereas the estimation was 0.03 USD resulting in a +6.52% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Genomma Lab Internacional SAB revenue for the last year?▼
Genomma Lab Internacional SAB revenue for the last year amounts to 2.77B USD.
What is Genomma Lab Internacional SAB net income for the last year?▼
GNMLF net income for the last year is 194.58M USD.
Does Genomma Lab Internacional SAB pay dividends?▼
Yes, GNMLF dividends are paid quarterly. The last dividend per share was 0.01 USD. As of today, Dividend Yield (FWD)% is 5.25%.
How many employees does Genomma Lab Internacional SAB have?▼
As of June 20, 2026, the company has 1,605 employees.
In which sector is Genomma Lab Internacional SAB located?▼
Genomma Lab Internacional SAB operates in the Health & Wellness sector.
When did Genomma Lab Internacional SAB complete a stock split?▼
The last stock split for Genomma Lab Internacional SAB was on August 03, 2010 with a ratio of 2:1.
Where is Genomma Lab Internacional SAB headquartered?▼
Genomma Lab Internacional SAB is headquartered in Mexico City, United States.